Ferric citrate OTAC dTAG-13 Robarge KD

Robarge KD

when PDT is combined with Dihydroartemisinin

Crizotinib (PF-02341066) hydrochloride (Xalkori) inhibits tyrosine phosphorylation of c-Met and nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) with IC50 of of 11 nM and 24 nM in cell-based assays

110(36):14622-7

Ferric citrate OTAC dTAG-13 Robarge KDFerric citrate (Iron(III) citrate), an orally active iron supplement, is an efficacious phosphate binder. Ferric citratee can be used for iron deficiency anemia and chronic kidney disease (CKD) research. Product information CAS Number: 3522 50 7 Molecular Weight: 244. 94 Formula: C6H5FeO7 Chemical Name: iron(3+) 2 hydroxypropane 1, 2, 3 tricarboxylate Smiles: [Fe+3].[O ]C(=O)C(O)(CC([O ])=O)CC([O ])=O InChiKey: NPFOYSMITVOQOS UHFFFAOYSA K InChi: